Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Sickle-Cell Disease Co-Management, Health Care Utilization, and Hydroxyurea Use
source: The Journal of the American Board of Family Medicine
year: 2020
authors: Crego N, Douglas C, Bonnabeau E, Earls M, Eason K, Merwin E, Rains G, Tanabe P, Shah N
summary/abstract:Background: Sickle-cell disease (SCD) causes significant morbidity, premature mortality, and high disease burden, resulting in frequent health care use. Comanagement may improve utilization and patient adherence with treatments such as Hydroxyurea. The purpose of this study was to describe acute-care utilization in Medicaid-enrolled patients with SCD, patient factors associated with comanagement, and adherence to Hydroxyurea.
Methods: Data from 2790 patients diagnosed with SCD, age 1 to 65+ years, enrolled at least 1 month in North Carolina Medicaid between March 2016 and February 2017, were analyzed. Outpatient visits were categorized as primary care, hematologist, and nonhematologist specialist. Nurse practitioners or physician assistants with unidentified specialty type or family practice were categorized separately. Comanagement was defined as a minimum of 1 primary care and 1 hematologist visit/patient during the study period.
Results: There were notable age-related differences in utilization of health care services. Only 34.82% of the sample was comanaged. Comanagement was higher in the 1-to-9-year-old (44.88%) and 10-to-17-year-old groups (39.22%) versus the 31-to-45-year-old (30.26%) and 65+-year-old (18.75%) age groups. Age had the greatest influence (AUC = 0.599) on whether or not a patient was comanaged. Only a third of the sample (32.24%) had at least 1 Hydroxyurea (HU) prescription. Age was the most predictive factor of good HUadherence (AUC = 0.6503). Prediction by comanagement was minimal with an AUC = 0.5615.
Conclusion: Comanagement was a factor in predicting HUadherence, but further studies are needed to identify the frequency and components of comanagement needed to increase adherence and reduce acute care utilization.
organization: Duke University School of Nursing, USA; Community Care of North Carolina, USA; University of Texas College of Nursing, USA; Duke University School of Medicine, USA; Duke University Medical Center, USADOI: https://doi.org/10.3122/jabfm.2020.01.190143
read more full text
Related Content
-
PCORI Board Approves $18 Million for Research on Sickle Cell DiseaseThe Patient-Centered Outcomes Research I...
-
Clinical Transformation in Care for Patients With Sickle Cell Disease at an Urban Academic Medical CenterThis article demonstrates effects on uti...
-
A Comparison of an Individualized and Weight-Based Opioid Protocols for the Treatment of Vaso-Occlusive Episodes in ...Introduction: Vaso-occlusive episodes ar...
-
Don’t Be Shy About Asking to Remain in the HospitalOne of the best feelings in the world is...
-
Sickle Cell Disease CoalitionThe Sickle Cell Disease Coalition (SCDC)...
-
Pfizer rare disease introduces Council for Change to further help SCD patientsFollowing a report earlier thi...
-
Dora Clayton-Jones, RN, PhD, CPNP-PCDr. Dora Clayton-Jones is an Assistant P...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.